Kestra Medical Technologies (KMTS) Reiterated at Buy by Stifel on Above-Average Growth
Tweet Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $30.00 price target on Kestra Medical Technologies (NASDAQ: KMTS).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
